Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results Of Zerenex (Ferric Citrate) For The Treatment Of Hyperphosphatemia
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced results of the Phase 2 study of Zerenex (ferric citrate) for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage renal disease (ESRD) on thrice weekly hemodialysis. The study was a multicenter, open-label clinical trial, which enrolled 55 patients. The primary objective of this study was to assess the tolerability and safety of Zerenex (ferric citrate) with doses ranging from approximately 1 gram per day to 12 grams per day.
generic viagra online
Senesco Presents Pre-Clinical Multiple Myeloma Data At The 12th Annual Meeting Of The American Society Of Gene Therapy
Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) announced that Richard Dondero, Vice President of Research and Development, will be presenting pre-clinical data from Senesco"s multiple myeloma studies at the 12th Annual Meeting of the American Society of Gene Therapy, which is being held at the San Diego Convention Center in San Diego, CA, from Wednesday, May 27th through to Saturday, May 30th, 2009. Mr. Dondero will be presenting in the afternoon session on Thursday, May 28th.
News of the day
Is It Legitimate To Stop Clinical Trials Early On Account Of Their "Opportunity Costs"?
A provocative debate in this week"s PLoS Medicine examines whether it
Cardiovascular

Baton Rouge, La.'s High AIDS Rate Examined

The Baton Rouge Advocate on Sunday examined reasons behind Baton Rouge, La."s high AIDS rate. The most recent data from CDC ranks the Baton Rouge metro area third nationally for AIDS cases for 2007, with 31.4 cases per 100,000 people, according to the article. "State health officials, medical professionals and people who work in HIV/AIDS prevention say there are a variety of reasons the Baton Rouge metro area ranks near the top," including delayed testing, denial of high-risk behavior among individuals and medical advances that are allowing people to live longer with the virus, the Advocate reports. Beth Scalco, the Louisiana director of the HIV/AIDS Program for the state Office of Public Health, said the city"s close proximity to four prisons also contributes to the high rates. Arnold "A.J." Johnson, founder of the Baton Rouge AIDS Society, said the government does not adequately fund HIV/AIDS education in the area. He added, "Part of the problem is the culture and atmosphere. The government needs to come here and attack this area like they did when Hurricane Katrina hit" (Ward, 7/26). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009